Antimicrobial composition

Details Antimicrobial composition Antimicrobial composition

2007-06-05

2007-06-05

Zeman, Robert A. (Department: 1645)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C424S093400, C424S165100, C424S164100, C424S130100, C424S184100

Reexamination Certificate

active

10505001

ABSTRACT:
This invention provides novelStreptococcus salivarius,compositions containing same, and use ofS. salivariusstrains as antimicrobial agents. The strains are bacterial inhibitors with respect to at leastS. mutansand/or MS and therefore have a number of therapeutic applications. The applications include but are not limited to forming part of therapeutic formulations for use in controlling, treating, or preventing dental caries.

REFERENCES:
patent: 3925160 (1975-12-01), Sanders, Jr. et al.
patent: 2004/0232205 (2004-11-01), Tagg et al.
patent: 0524732 (1992-06-01), None
patent: WO 00/05972 (2000-02-01), None
patent: WO 01/27143 (2001-04-01), None
James et al (The prevention of dental caries by BLIS-mediated inhibition of mutans Streptococci, New Zealand Dental Journal, 1991; 87: 80-83).
Soderling et al (Influence of maternal xylitol consumption on mother-child transmission of mutans streptococci: 6-year follow-up, 2001;35: 173-77).
Balakrishnan et al (Diverse activity spectra of bacteriocin like inhibitory substances having activity against mutans streptococci, Caries Research, 2001;35: 75-80).
Ross, et al (Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA fromStreptococcus salivarius20P3, Applied and Environmental Microbiology, 1993;59(7): 2014-21).
Tanzer et al., “Competitive Displacement of Mutans Streptococci and Inhibition of Tooth Decay byStreptococcus salivariusTOVE-R,”Infection and Immunity,Apr. 1985, vol. 48, No. 1.
Tanzer et al., “Inhibition of Ecological Emergence of Mutans Streptococci Naturally Transmitted Between Rats and Consequent Caries Inhibition ByStreptococcus salivariusTOVE-R Infection,” Infection and Immunity, vol. 49, No. 1, pp. 76-83, 1985.
Dempster et al., “The Production of Bacteriocin-like Substances by the Oral BacteriumStretococcus salivarius,” Archives or Oral Biology,vol. 27, pp. 151 to 157, 1982.
Balakrishnan, et al., “Diverse Activity Spectra of Bacteriocin-like Inhibitory Substances Having Activity Against Mutans Streptococci,”Caries Research,35: pp. 75-80, 2001.
Hillman, et al., “Colonization of the Human Oral Cavity,”Journal of Dental Research,vol. 66(6), pp. 1092-1094, Jun. 1987.
James, et al., “The Prevention of Dental Caries by BLIS-mediated Inhibition of Mutans Streptococci,”New Zealand Dental Journal,vol. 87, pp. 80-83, 1991.
Nagawa, et al., “Preparation of the Bifidus Milk Powder,”Journal of Dairy Science,vol. 71, pp. 1777-1782, 1988.
Thompkins, “Antagonistic Interactions among Numerically Prominent Members of the Human Oral Microbiota,”A thesis submitted for the degree of Doctor of Philosophy at the University of Otago, Dunedin, New Zealand,1986.
Thompkins, et al., “Bacteriocin-like Inhibitory Activity Associates with Beta-hemolytic Strains ofStreptococcus salivarius,” Journal of Dental Research,vol. 66, No. 8, pp. 1321-1325, 1987.
Thompkins, et al., “The Ecology of Bacteriocin-producing Strains ofStreptococcus salivarius,” Microbial Ecology in Health and Disease,vol. 2, pp. 19-28, 1989.
Kurasz A. B. et al., “In vitro studies of growth and competition betweenS. salivariusTOVE-R andmutans streptococci;” Journal of Dental Research, Sep. 1996, vol. 65, No. 9, pp. 1149-1153.

Affiliated with

Also associated with

Rating

Antimicrobial composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antimicrobial composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3810187